Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27747,109,0.70 [0.53-0.94],0.0155010660971315
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28326,148,0.92 [0.67-1.27],0.6187416820820651
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",28074,1012,0.84 [0.75-0.94],0.003035714071035
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,28360,307,0.78 [0.64-0.95],0.0123487679398003
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27566,2798,0.89 [0.83-0.95],0.0012445420006538
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27813,2107,0.86 [0.79-0.93],0.0001883140750518
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,28143,1013,0.88 [0.78-0.99],0.0394639322460278
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,28272,45,0.76 [0.46-1.25],0.2722372607868311
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,27074,650,0.83 [0.72-0.95],0.0074872053599485
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,26186,629,0.82 [0.71-0.94],0.005632605123819
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26429,176,0.82 [0.63-1.07],0.1417508950317509
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,21117,1226,0.84 [0.76-0.93],0.0008984798310717
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26181,288,0.84 [0.68-1.04],0.1054992372231918
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,28311,1181,0.91 [0.81-1.01],0.0795708124923774
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Mycoses,28422,369,0.79 [0.66-0.95],0.0109562558068508
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27677,615,0.77 [0.67-0.88],0.0001129518133954
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28358,720,0.83 [0.72-0.94],0.004601048476343
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27280,150,0.86 [0.64-1.17],0.3385370381858689
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28464,33,0.64 [0.39-1.03],0.0658039574301272
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,28266,628,0.84 [0.73-0.97],0.0174674962348928
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28301,74,1.34 [0.79-2.29],0.2806195073864106
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28372,177,0.98 [0.73-1.33],0.9163753121001212
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28356,161,0.92 [0.68-1.26],0.6129130833408571
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27398,336,0.77 [0.64-0.92],0.0036810661716043
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27309,247,0.98 [0.76-1.27],0.8684623207891535
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,27212,82,0.81 [0.55-1.20],0.2966909502806453
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28437,55,1.11 [0.63-1.97],0.7084328867389424
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28400,133,0.77 [0.58-1.04],0.0859959397591533
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral warts,28312,45,0.80 [0.47-1.36],0.4131896753218509
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],28318,51,0.65 [0.44-0.95],0.0276232422415268
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm,28170,321,0.92 [0.74-1.14],0.4387759221583498
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28372,77,0.78 [0.53-1.16],0.2210026374328473
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28351,81,0.89 [0.58-1.36],0.590968496602742
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12684,45,0.84 [0.50-1.43],0.5254745227474069
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",28265,1217,0.91 [0.81-1.01],0.077563990903657
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of meninges,28453,51,0.92 [0.53-1.60],0.7709350776170052
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28427,51,0.82 [0.50-1.34],0.4321306925005881
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28441,96,0.67 [0.49-0.90],0.0086750371151014
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of ovary,15717,101,1.02 [0.67-1.55],0.9215950172360372
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28457,285,1.01 [0.79-1.28],0.9427099633692664
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Caecum,28453,211,0.77 [0.61-0.98],0.0302191271950375
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28394,60,1.46 [0.80-2.68],0.2154127213789635
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,28456,181,0.90 [0.68-1.19],0.4646563933043591
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Rectum,28418,301,0.83 [0.67-1.01],0.0667545413562722
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28387,563,0.95 [0.80-1.12],0.5327171905687809
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28458,324,0.84 [0.69-1.03],0.0957754254790288
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Carcinoma in situ of breast,13507,91,0.89 [0.59-1.33],0.5625437932941401
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13555,104,1.03 [0.68-1.56],0.8834767826672468
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24580,31,0.81 [0.44-1.50],0.5018905926651857
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24589,40,0.94 [0.51-1.73],0.854426981955302
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28420,115,0.86 [0.61-1.21],0.3776265301254683
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Haemangioma, any site",28420,113,0.88 [0.62-1.26],0.4931311455819428
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Leiomyoma of uterus,15068,428,1.19 [0.96-1.49],0.1113848878015128
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Lung cancer and mesothelioma,21146,178,0.60 [0.49-0.75],6.164489467997026e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Lymphoid leukaemia,24579,30,0.81 [0.43-1.50],0.502351699940501
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24699,150,1.19 [0.83-1.70],0.3458339550161834
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24639,90,1.45 [0.89-2.36],0.139690887308202
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13610,85,1.45 [0.86-2.45],0.168162376004218
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24603,54,0.91 [0.54-1.52],0.7190178560690308
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24619,70,1.06 [0.65-1.72],0.8261722231779275
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24622,73,0.90 [0.59-1.38],0.6216725671503215
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13581,56,1.21 [0.66-2.23],0.5384404905041992
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24608,59,1.00 [0.59-1.69],0.9999048189195336
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11447,423,1.17 [0.95-1.43],0.1491554146354978
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24642,93,0.88 [0.60-1.29],0.5030663183802373
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24606,57,0.69 [0.46-1.02],0.0661226977509923
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24614,65,0.79 [0.52-1.21],0.2781554774386501
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanocytic naevi,28215,218,1.01 [0.77-1.34],0.9252143564979188
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanocytic naevi of trunk,28411,98,1.27 [0.81-1.99],0.3052834331991807
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanoma in situ,24564,52,0.64 [0.44-0.93],0.018681863331883
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24610,61,0.87 [0.55-1.38],0.5426403758761758
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24670,121,0.75 [0.56-1.00],0.0477827165232365
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24669,120,0.62 [0.47-0.81],0.0005018812313608
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24619,70,0.58 [0.43-0.77],0.0001439009059065
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Other benign neoplasms of skin,28275,146,0.87 [0.64-1.18],0.3729519845805945
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",25213,664,1.04 [0.88-1.22],0.6524372151291427
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",25245,696,1.07 [0.92-1.26],0.3854488956728225
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28184,294,0.88 [0.71-1.10],0.2659754417501999
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,27001,60,0.86 [0.54-1.37],0.5141821580198935
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27962,72,0.81 [0.53-1.22],0.3127217498276317
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27643,2302,0.86 [0.80-0.93],0.000168934163536
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,27239,24,1.26 [0.51-3.08],0.6140957153295898
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,28099,37,0.79 [0.45-1.38],0.4041559192234156
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,28008,1067,0.78 [0.70-0.86],2.021384049320593e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,28008,1067,0.78 [0.70-0.86],2.021384049320593e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,27001,60,0.83 [0.52-1.31],0.4239765510745261
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,28174,959,0.90 [0.79-1.02],0.0863678550198431
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,28176,114,0.92 [0.64-1.32],0.6454995845688998
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27944,54,0.82 [0.51-1.31],0.4078453066988508
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27933,43,0.70 [0.44-1.11],0.1307135755073835
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,28262,200,0.81 [0.63-1.04],0.0930104117383189
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28382,72,0.71 [0.49-1.03],0.0699123920402759
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",28230,168,0.79 [0.61-1.03],0.0811593523075797
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,27292,77,0.68 [0.48-0.95],0.023803488866811
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24464,222,0.69 [0.57-0.84],0.0002384511726531
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26479,130,0.66 [0.52-0.84],0.0006944798330997
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26493,144,0.64 [0.51-0.81],0.0001482416453097
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24280,38,0.70 [0.42-1.16],0.1657900013267594
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26423,70,1.17 [0.70-1.97],0.5537556972948463
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,26079,155,0.66 [0.52-0.84],0.0006588704568699
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",28314,172,0.81 [0.62-1.06],0.1260978197511055
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,28190,48,1.61 [0.81-3.23],0.175523871393402
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,28180,38,1.06 [0.54-2.08],0.8704333460994091
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,28042,1689,0.85 [0.77-0.93],0.0003128309389075
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25484,1639,0.82 [0.75-0.90],2.5168786647598176e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24283,41,0.74 [0.44-1.24],0.2544620223297449
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26734,58,0.82 [0.50-1.32],0.4089939791888151
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24434,192,0.67 [0.55-0.83],0.0001910992104222
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24309,67,1.23 [0.72-2.11],0.4472369360984418
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26699,2457,0.85 [0.79-0.91],1.1010922404201227e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24366,124,0.74 [0.56-0.98],0.0352029812062152
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24640,398,0.76 [0.64-0.89],0.0006870711403563
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28360,282,0.72 [0.60-0.87],0.0007652012402393
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,28194,116,0.66 [0.50-0.86],0.0026424043173978
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24340,98,0.74 [0.54-1.00],0.0513042940470869
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24281,39,1.57 [0.73-3.37],0.2492869758023526
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,28020,1344,0.86 [0.77-0.95],0.003666541264015
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24376,134,0.71 [0.55-0.92],0.0086534621052254
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24413,171,0.70 [0.56-0.88],0.0022476276738581
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24643,401,0.77 [0.65-0.90],0.0015095854738916
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24304,62,0.79 [0.52-1.21],0.2776278237813386
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,28187,109,0.67 [0.50-0.89],0.0053962413836587
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24552,310,0.69 [0.58-0.81],1.0796173362486198e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24544,302,0.73 [0.61-0.88],0.000877015653672
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25982,58,0.76 [0.49-1.19],0.2379132181842693
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27760,3518,0.84 [0.79-0.89],5.516844112198595e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26713,37,0.80 [0.45-1.43],0.4486254434848354
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26737,61,0.75 [0.49-1.16],0.1963859035804318
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,28274,1982,0.82 [0.76-0.90],6.13566538135866e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",28278,1979,0.83 [0.76-0.90],9.6008570646727e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26715,39,0.59 [0.39-0.91],0.0166638058599916
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,28130,1280,0.88 [0.79-0.98],0.0196774866975555
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",25171,929,0.74 [0.67-0.82],1.5937618185487716e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28454,139,0.84 [0.62-1.15],0.2763629554206274
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,28177,35,0.63 [0.41-0.98],0.0401615125468698
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26940,90,0.76 [0.53-1.08],0.128096771929297
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26966,116,0.88 [0.62-1.25],0.4696617825290939
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",24379,137,0.68 [0.52-0.88],0.0033980683908321
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26624,125,0.77 [0.57-1.03],0.0806436837077594
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1752,71,0.69 [0.50-0.94],0.0206216390243903
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1862,196,0.93 [0.71-1.22],0.608757420752811
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26539,40,0.77 [0.45-1.30],0.3239544620893946
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1718,37,1.21 [0.60-2.43],0.5945618170264799
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,28024,1525,0.87 [0.79-0.96],0.006043656774152
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,28215,73,0.75 [0.51-1.09],0.1270855212724236
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,26206,282,0.86 [0.68-1.07],0.1774752218533305
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24668,426,0.87 [0.72-1.04],0.1154940536191912
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28373,182,0.83 [0.64-1.08],0.155788101885279
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27711,57,0.64 [0.45-0.90],0.0116270727219292
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Angina pectoris,27153,813,0.85 [0.75-0.97],0.0135598669406727
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27760,106,0.78 [0.57-1.08],0.1377141421298581
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27683,29,0.62 [0.40-0.96],0.032997786971875
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27761,107,0.65 [0.50-0.85],0.0012986133724354
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20320,973,0.80 [0.72-0.89],3.022455348911679e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,AV-block,25917,189,0.94 [0.71-1.24],0.6464038219434161
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28430,262,1.06 [0.82-1.37],0.6427999800411344
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,19464,117,0.73 [0.55-0.97],0.0327731755153311
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25863,135,0.72 [0.55-0.94],0.0163942476693709
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25810,82,0.59 [0.45-0.78],0.0001909315644681
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28466,21,0.57 [0.35-0.95],0.0301154023426888
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Conduction disorders,26273,545,0.87 [0.74-1.02],0.0821151815440325
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27724,1395,0.86 [0.78-0.95],0.0020878339759215
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26477,6202,0.88 [0.84-0.92],4.6191510332121086e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27267,190,0.83 [0.64-1.07],0.1500631617837502
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Endocarditis,25772,44,0.74 [0.46-1.21],0.2355059042148848
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28344,526,0.73 [0.64-0.84],5.778577015384197e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertension,27063,5047,0.86 [0.82-0.91],1.6014501168808542e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",27079,5063,0.86 [0.82-0.91],1.5667972102551072e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",28292,59,1.05 [0.62-1.77],0.8630494905168653
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22105,89,0.62 [0.47-0.81],0.0006608917882549
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,22081,65,0.88 [0.56-1.39],0.5972076673294588
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypotension,28358,712,0.83 [0.73-0.95],0.0071159283578106
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27923,66,1.06 [0.64-1.77],0.8154579818225343
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27894,1554,0.85 [0.78-0.93],0.0005179748616874
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28231,314,0.90 [0.73-1.11],0.3274108972505796
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25926,198,0.77 [0.60-0.97],0.0263780533172356
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28203,613,0.86 [0.75-1.00],0.0492997692888752
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26839,499,0.80 [0.68-0.93],0.0029188491908607
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28407,119,0.82 [0.60-1.12],0.2132823819581481
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28450,208,0.85 [0.66-1.09],0.1897388982940221
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,27119,42,1.01 [0.55-1.88],0.9640525523428624
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other aneurysm,27706,52,0.77 [0.48-1.23],0.2714507402559436
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,25973,245,0.84 [0.66-1.05],0.1308093426071237
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27718,64,0.68 [0.48-0.96],0.0291484533222723
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27801,147,0.74 [0.56-0.96],0.0232232489359077
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25857,129,0.90 [0.65-1.27],0.5569313276229084
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,27151,74,0.76 [0.51-1.11],0.1538199385622932
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,27125,48,1.15 [0.61-2.17],0.6543983727158342
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27665,37,0.64 [0.41-0.98],0.040571004568944
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,27170,93,0.60 [0.45-0.79],0.0003297272008299
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26331,603,0.85 [0.74-0.99],0.0337395221903112
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27694,48,1.06 [0.58-1.92],0.8515123146286865
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,28004,350,0.67 [0.57-0.78],2.8905845338286855e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,28011,160,0.64 [0.51-0.79],4.081751960971322e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27867,239,0.82 [0.65-1.02],0.0788940209450527
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19607,260,0.72 [0.59-0.87],0.0005782956929776
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27840,211,0.65 [0.54-0.78],5.844890956488817e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27339,262,0.87 [0.69-1.09],0.2146096920720304
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28196,345,1.07 [0.85-1.34],0.5577389668335935
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28424,339,0.82 [0.68-1.00],0.0489985189809962
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25908,180,0.87 [0.66-1.14],0.3142999786021531
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,28007,156,0.64 [0.51-0.79],5.750887061088821e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27749,121,0.68 [0.52-0.89],0.0046295683621963
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28224,367,0.92 [0.75-1.12],0.4097750046373407
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28197,404,0.93 [0.77-1.13],0.4896755723881455
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27898,56,1.27 [0.69-2.33],0.4411833790792701
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27710,57,0.89 [0.55-1.46],0.6463993805359534
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,28063,146,0.83 [0.62-1.11],0.2139192135920042
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27773,183,1.19 [0.86-1.64],0.287343151470104
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Varicose veins,27407,330,0.86 [0.70-1.05],0.1310338955114605
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27663,49,0.97 [0.55-1.71],0.9042868841576835
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28287,545,0.97 [0.82-1.14],0.6968027260691835
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28303,388,0.75 [0.63-0.88],0.0003970167493116
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25375,1470,0.87 [0.79-0.96],0.0057663931840116
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Any mental disorder,27688,3783,0.85 [0.80-0.90],7.690763011221611e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28237,460,0.72 [0.63-0.84],1.3514320804886368e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25623,1718,0.84 [0.77-0.91],8.078411194253705e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23997,92,0.79 [0.55-1.13],0.2024413101072977
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Smoking dependency,27909,1566,0.85 [0.78-0.93],0.000393458212977
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25724,1819,0.81 [0.74-0.87],1.412429116460999e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Vascular dementia,28347,22,0.65 [0.37-1.14],0.1300096725158648
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Alzheimer disease,28466,67,1.35 [0.77-2.36],0.2931377985897995
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Bell's palsy,26757,76,0.76 [0.52-1.11],0.1624331627409992
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27173,492,0.91 [0.76-1.08],0.2833771098023235
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Cerebral cysts,28099,210,0.87 [0.67-1.12],0.2792883568801222
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28382,236,0.79 [0.63-0.98],0.0315927410789569
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,28321,24,1.23 [0.49-3.09],0.6551723100239136
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28451,51,0.69 [0.45-1.04],0.0753374773915214
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27948,59,0.99 [0.59-1.66],0.9641641107206635
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Epilepsy,26852,267,0.75 [0.61-0.91],0.0040612072033489
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27972,1387,0.84 [0.76-0.92],0.0003962842137187
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28435,278,0.92 [0.73-1.16],0.4697125206087869
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27935,1691,0.86 [0.78-0.94],0.0006681016913676
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,28085,52,0.59 [0.42-0.81],0.0013138361061002
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Hemiplegia,28316,170,0.79 [0.61-1.03],0.0766128821180198
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Hydrocephalus,27936,47,0.96 [0.54-1.69],0.874951231292102
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28442,61,0.96 [0.58-1.59],0.8791569340562779
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26764,83,1.12 [0.69-1.81],0.6405703286886302
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26771,90,1.09 [0.70-1.70],0.7040988423826942
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Memory loss,28311,74,0.67 [0.48-0.93],0.0154429057513344
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Migraine,27024,439,0.78 [0.66-0.92],0.0035189850332302
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28374,390,0.73 [0.62-0.86],0.0002373596174176
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Motor neuron disease,20725,99,1.03 [0.68-1.55],0.8965229312668168
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28266,146,0.69 [0.54-0.89],0.0046598846169224
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27846,1165,0.89 [0.80-1.00],0.0435955905396939
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Neurological diseases,27007,3175,0.88 [0.82-0.94],8.874388421517704e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28373,76,0.79 [0.54-1.16],0.2274473837139785
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",27077,396,0.94 [0.78-1.15],0.5709861840154653
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28392,239,0.79 [0.64-0.99],0.0374019197655734
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23745,313,0.80 [0.66-0.97],0.024762972924397
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27951,62,0.93 [0.57-1.52],0.7746914475641385
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,28007,118,0.82 [0.59-1.14],0.240111482948382
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,28248,91,0.97 [0.64-1.46],0.8707237676964954
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26775,94,0.69 [0.51-0.94],0.0201825499392362
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other headache syndromes,26646,61,0.70 [0.46-1.05],0.0858465986394031
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other neurological diseases,28341,452,0.90 [0.75-1.07],0.2361429469209769
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other sleep disorders,27184,599,0.89 [0.77-1.04],0.1479632368232089
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Parkinson's disease,28453,166,1.02 [0.75-1.40],0.8871410261719314
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27955,66,0.98 [0.59-1.61],0.9269129239184292
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,28465,45,1.83 [0.88-3.80],0.1048028556718429
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Sleep apnoea,28211,520,0.85 [0.73-1.00],0.0537853609454924
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,28189,36,0.86 [0.47-1.58],0.626142484634515
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28450,126,0.90 [0.64-1.26],0.5299271349391257
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26714,33,0.63 [0.39-1.01],0.0555494724508755
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28466,68,1.35 [0.77-2.35],0.2915101142346797
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28334,21,0.66 [0.37-1.18],0.1631839213442863
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27972,43,0.87 [0.50-1.51],0.6101494200143978
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,28109,225,0.92 [0.71-1.19],0.5335908922549981
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28374,200,0.89 [0.68-1.16],0.3959406293274758
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27702,38,1.01 [0.51-1.98],0.975572563962966
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27738,74,0.68 [0.48-0.95],0.0236817248113766
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",28374,32,0.84 [0.44-1.60],0.5879751472653012
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,28262,66,1.04 [0.62-1.73],0.889246773002353
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1724,43,1.46 [0.73-2.94],0.2891755023378319
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2037,87,0.73 [0.53-1.00],0.0487336701179801
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,28005,76,1.15 [0.70-1.89],0.5806873169462559
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28335,638,0.95 [0.81-1.11],0.5157025017572148
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",28152,488,0.85 [0.72-1.01],0.0632841030089333
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27804,140,0.88 [0.64-1.22],0.4397348124096275
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28371,487,0.96 [0.80-1.16],0.6931797148930248
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28453,54,0.83 [0.51-1.36],0.4661144580211946
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,28299,415,0.97 [0.80-1.18],0.7729219558216228
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28422,226,0.86 [0.67-1.10],0.2366301771734954
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,28400,130,0.77 [0.57-1.04],0.0846004160350382
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27682,18,1.04 [0.39-2.76],0.9332711639049792
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27693,29,0.56 [0.36-0.86],0.0087627113226553
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27697,33,1.09 [0.52-2.31],0.8151264360647438
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28416,398,0.98 [0.80-1.20],0.8272232812585827
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,28121,103,0.88 [0.61-1.28],0.5150088280620413
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27909,25,3.67 [1.32-10.21],0.0126211266119759
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,28272,76,0.95 [0.60-1.50],0.8283838174371638
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,28347,151,0.83 [0.62-1.11],0.2111884091763664
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,28050,166,0.88 [0.66-1.18],0.4072214580813412
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,28347,77,0.73 [0.50-1.04],0.0823733592045641
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28279,261,1.01 [0.78-1.30],0.9409535971807458
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,28050,121,0.70 [0.53-0.92],0.0110817607800241
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27733,1086,0.93 [0.83-1.05],0.2620935854448963
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,28321,125,0.87 [0.62-1.21],0.3982690684226151
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28439,115,1.04 [0.71-1.54],0.8255740191543277
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27936,272,0.92 [0.73-1.16],0.4752513180155797
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,28235,39,0.98 [0.52-1.88],0.9617607058112976
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28437,38,0.81 [0.46-1.45],0.4852285027250842
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27702,38,0.71 [0.43-1.17],0.1814460274216361
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27784,120,1.11 [0.75-1.65],0.5979863069774946
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27769,72,0.78 [0.52-1.17],0.233945899875171
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27942,58,0.95 [0.57-1.59],0.8418096342968752
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27745,48,1.45 [0.74-2.84],0.2804680489112962
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,28077,59,1.27 [0.70-2.30],0.4320544694833101
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",28114,96,0.97 [0.64-1.45],0.8754389406005856
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27757,93,0.70 [0.51-0.97],0.0302789128923283
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27823,126,0.94 [0.67-1.33],0.7406994658817547
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27734,37,0.56 [0.38-0.83],0.0036633046083123
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27500,853,0.99 [0.86-1.14],0.9304929938316684
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27714,50,0.80 [0.49-1.32],0.390313559234299
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28243,314,0.83 [0.68-1.01],0.0671187846139296
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27968,39,0.82 [0.47-1.44],0.4977373231350243
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),28061,132,0.80 [0.59-1.09],0.1561903215705922
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,28265,62,0.86 [0.53-1.38],0.5228371168479187
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28423,101,0.97 [0.65-1.45],0.8962415685988664
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,28344,138,0.91 [0.66-1.26],0.5739294090829863
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,28258,55,0.77 [0.49-1.20],0.2459039094719147
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,28259,56,1.24 [0.68-2.26],0.4804510222359129
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28377,542,0.75 [0.65-0.86],3.5457002323051524e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,28171,336,0.75 [0.62-0.89],0.0010881851054958
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27934,99,0.71 [0.52-0.97],0.0339399045413932
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27917,82,0.95 [0.61-1.46],0.8071141790382055
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,28169,84,0.92 [0.60-1.40],0.681163924588398
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28325,240,0.88 [0.69-1.13],0.3237150240346577
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,28149,64,0.77 [0.50-1.17],0.2223171706451842
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,All influenza,27117,80,0.66 [0.48-0.91],0.0102031943671373
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),27115,78,0.65 [0.47-0.90],0.0092474842894133
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),21098,130,1.07 [0.74-1.56],0.7068435338290318
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,28308,323,1.12 [0.88-1.42],0.3646789668126629
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22636,1814,0.90 [0.82-0.98],0.0198343617949363
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22753,1785,0.89 [0.81-0.98],0.0125076698050984
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),28171,97,0.87 [0.59-1.27],0.4690134900816123
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",27096,59,0.91 [0.55-1.52],0.7293460963530256
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Bronchiectasis,25339,185,0.76 [0.59-0.97],0.0291742969227386
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",25197,43,0.87 [0.48-1.57],0.6429700156231256
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27578,2424,0.87 [0.80-0.94],0.0002275179510044
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26940,69,0.95 [0.60-1.52],0.8417836651522039
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,27045,174,1.21 [0.86-1.69],0.2675179808570915
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28356,737,0.75 [0.66-0.84],3.0551066447063003e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,27002,131,0.99 [0.70-1.41],0.9678780789875856
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26488,4380,0.87 [0.82-0.92],1.5228522512464268e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27259,388,0.81 [0.68-0.97],0.0230240349704699
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Early onset COPD,28138,519,0.71 [0.62-0.81],8.896866502966724e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Emphysema,25343,189,0.69 [0.54-0.87],0.0017229940239382
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27182,118,0.80 [0.58-1.11],0.1758262645351549
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,28278,1241,0.82 [0.74-0.90],6.80694903088434e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,27208,144,0.77 [0.58-1.03],0.0778735761664208
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Later onset COPD,26985,218,0.87 [0.67-1.14],0.3115720535654028
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28458,160,0.70 [0.55-0.88],0.0027022532701166
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Nasal polyp,26986,115,0.80 [0.58-1.11],0.1845410682683048
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28251,633,0.81 [0.71-0.93],0.003549608338047
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,28282,1276,0.79 [0.72-0.87],8.109189270706338e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27788,917,0.92 [0.81-1.05],0.2326356507908029
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other pleural conditions,27040,34,0.80 [0.44-1.45],0.4670344395522002
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28409,207,0.80 [0.63-1.02],0.0746294158600415
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28380,868,0.76 [0.68-0.85],1.8538732499642648e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural effusion,27617,611,0.85 [0.74-0.99],0.0364390156396598
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural plaque,27063,57,0.80 [0.52-1.24],0.3203568875703669
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",28065,1028,0.79 [0.71-0.88],1.0058315814701672e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28437,139,0.70 [0.54-0.90],0.0057568268000878
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pneumothorax,27071,65,0.77 [0.51-1.17],0.2220335160906182
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pollen allergy,28429,275,1.16 [0.90-1.51],0.2564667585832918
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,28241,39,0.71 [0.43-1.16],0.1726053416498969
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,21006,38,0.55 [0.37-0.81],0.0029382417290736
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28232,614,0.82 [0.71-0.94],0.0049609159543181
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,27194,323,1.11 [0.87-1.41],0.3910697563977666
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Viral pneumonia,27233,196,0.95 [0.72-1.25],0.7009529581204881
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",28191,168,1.05 [0.76-1.45],0.7598515447768681
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16435,107,0.75 [0.54-1.03],0.0770343930009251
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21764,66,0.65 [0.47-0.89],0.0075264968981561
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute appendicitis,28258,162,1.12 [0.80-1.57],0.5078587836893287
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute gastritis,22744,77,0.73 [0.51-1.05],0.0911205082427553
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,26820,170,0.80 [0.61-1.03],0.0844547544439209
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute peritonitis,28013,77,1.13 [0.69-1.84],0.6281092876331673
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27660,87,0.68 [0.50-0.91],0.0089501033646646
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,23031,364,0.83 [0.69-1.00],0.0457031671878386
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26708,58,0.76 [0.49-1.17],0.2165940311649916
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",28043,58,0.77 [0.50-1.19],0.2345555817992313
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Cholecystitis,26838,188,0.82 [0.63-1.06],0.1252343721701741
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Cholelithiasis,27586,936,0.88 [0.78-1.00],0.0495362828193666
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Chronic gastritis,22931,264,1.19 [0.90-1.56],0.2146494901969505
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26694,44,0.55 [0.40-0.77],0.0003996022220093
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",28314,81,0.96 [0.62-1.48],0.8588623166199272
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Coeliac disease,26988,122,0.92 [0.65-1.31],0.6618041661054284
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Collagenous colitis,26847,63,1.17 [0.67-2.03],0.5880547998402502
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28274,216,1.09 [0.82-1.46],0.5367162335680107
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Constipation,28238,1214,0.87 [0.78-0.97],0.0092978640266818
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Crohn disease,26884,100,0.94 [0.64-1.39],0.7587736940396377
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",28108,71,1.26 [0.74-2.14],0.3943187172903122
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26881,97,0.91 [0.62-1.34],0.6340023418359932
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Dental caries,27593,273,0.73 [0.60-0.88],0.0010144704796999
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26342,1887,0.92 [0.84-1.01],0.0643694760944107
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of appendix,28301,205,1.11 [0.82-1.49],0.5104639599552547
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of liver,28343,770,0.85 [0.74-0.97],0.0142100435848734
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26712,4045,0.94 [0.88-1.00],0.0461171653800369
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27960,640,0.81 [0.71-0.93],0.003018412038526
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28384,448,1.02 [0.84-1.24],0.8592319320054075
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27457,137,0.69 [0.53-0.89],0.003755719143851
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,27287,73,0.89 [0.57-1.38],0.5882360818549746
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,28180,1314,0.87 [0.79-0.96],0.0076116212942764
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of tongue,27300,125,1.03 [0.71-1.49],0.8733258974179039
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27933,1283,0.86 [0.78-0.96],0.0056401170420297
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,24223,2525,0.93 [0.86-1.00],0.0590277816780836
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,22815,148,1.06 [0.76-1.50],0.7197892058111581
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28395,118,1.17 [0.79-1.74],0.4282155823301621
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28324,82,0.88 [0.58-1.32],0.5243898750358222
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27677,104,0.97 [0.66-1.42],0.8855570777242449
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21886,188,1.09 [0.80-1.48],0.5714055844216437
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,23197,530,0.98 [0.82-1.17],0.8402979653240296
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastric ulcer,22954,287,0.72 [0.60-0.87],0.0005010800844588
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24995,2328,0.93 [0.85-1.01],0.0659197568003296
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,23082,415,0.81 [0.68-0.96],0.0152985134625992
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23245,8356,0.95 [0.91-0.99],0.0168625223772218
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,GI-bleeding,27925,1059,0.87 [0.77-0.97],0.012829207975665
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27384,64,0.80 [0.52-1.23],0.3102490593385298
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22660,1337,0.98 [0.88-1.09],0.7337293296026184
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27629,56,1.25 [0.69-2.24],0.4654699758705075
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Hernia,27275,2820,0.91 [0.85-0.98],0.0133340338696477
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Impacted teeth,28334,76,0.86 [0.56-1.31],0.4745249214801795
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Impaction of intestines,21731,33,0.67 [0.41-1.11],0.1169166722926079
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Inguinal hernia,25149,694,0.86 [0.75-0.99],0.0364403431680337
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",24535,80,0.91 [0.60-1.38],0.6455229060766708
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21775,77,1.18 [0.71-1.94],0.5232763880259432
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,27009,143,0.91 [0.66-1.26],0.570524593763031
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22289,591,0.88 [0.75-1.03],0.1036272510338076
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28439,403,0.90 [0.75-1.09],0.2909629039986426
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27512,728,0.92 [0.80-1.06],0.2578789989069437
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27706,922,0.92 [0.81-1.04],0.1840912738335198
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22824,157,0.72 [0.56-0.92],0.0099535418787817
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oesophagitis,23173,506,0.82 [0.70-0.96],0.0154810411788449
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28422,140,1.14 [0.79-1.64],0.4826576598584475
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,24505,50,0.68 [0.45-1.03],0.0684685188542959
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,23044,1346,0.96 [0.86-1.06],0.4112553505324474
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26855,205,0.73 [0.59-0.92],0.0062564810345577
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26816,166,0.84 [0.63-1.11],0.2178030172790023
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,23251,1553,0.93 [0.84-1.02],0.1278049533355383
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,26762,5064,0.94 [0.89-1.00],0.0360334839645682
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27295,207,1.09 [0.81-1.47],0.5592041168106457
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of liver,28195,622,0.87 [0.75-1.01],0.0637940336597816
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,23228,561,0.75 [0.65-0.86],3.3199905201659226e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26739,89,0.82 [0.56-1.20],0.3169350842134318
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28324,388,0.98 [0.80-1.21],0.877475683296439
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23475,808,0.84 [0.74-0.96],0.009259005184615
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27939,1073,0.87 [0.78-0.97],0.0136319112897582
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27516,196,0.99 [0.74-1.33],0.9694656366303572
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22962,1264,0.87 [0.78-0.97],0.0091485379013181
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24513,1846,0.91 [0.83-1.00],0.0417435571576647
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27659,86,1.36 [0.83-2.22],0.2229241937665065
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27589,805,0.94 [0.82-1.08],0.3601164268395805
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21935,237,1.06 [0.81-1.39],0.6730957327212324
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28308,98,0.83 [0.58-1.19],0.311195313303521
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,22056,358,0.99 [0.80-1.23],0.943665405533851
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",27006,140,0.91 [0.66-1.26],0.5828871839103995
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28457,60,1.18 [0.67-2.08],0.5701448206254551
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27338,133,1.14 [0.78-1.65],0.4949505544354785
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Toxic colitis,26817,33,1.03 [0.50-2.14],0.93343566313376
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22860,193,0.93 [0.70-1.22],0.5939611203150016
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,26936,152,0.79 [0.60-1.05],0.1004719671841791
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26915,131,0.75 [0.56-0.99],0.0447247542242808
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Umbilical hernia,24740,285,1.01 [0.79-1.28],0.9431726204416324
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21803,105,0.96 [0.65-1.40],0.816491638500429
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ventral hernia,24684,229,1.09 [0.82-1.44],0.5549854621125616
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Volvulus,21765,67,0.74 [0.50-1.09],0.12623949257144
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,28407,165,1.22 [0.86-1.73],0.2568558264829624
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,28186,81,0.77 [0.53-1.11],0.1582314509931437
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26936,152,0.87 [0.64-1.19],0.3936291048262695
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27824,577,0.81 [0.70-0.94],0.0058404196992647
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27452,205,0.83 [0.65-1.07],0.1518131874142897
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26965,181,0.65 [0.53-0.80],4.633094717398311e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,28198,236,1.11 [0.84-1.47],0.4690350088539883
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28367,405,0.87 [0.72-1.05],0.1404643645580351
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,28011,49,0.64 [0.43-0.97],0.0334989076273932
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26957,2670,0.86 [0.80-0.93],5.518286396903854e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27997,455,0.86 [0.72-1.03],0.096896863722096
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27867,325,0.91 [0.73-1.12],0.3768649065575313
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,28065,818,0.83 [0.73-0.94],0.0025489443236386
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28452,49,0.60 [0.41-0.86],0.0061543071177551
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26841,57,0.65 [0.44-0.95],0.0280123868321468
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27583,41,0.65 [0.41-1.01],0.0559831841806047
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,28191,229,1.13 [0.85-1.51],0.3889746715071137
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,27080,296,1.03 [0.81-1.31],0.7858149915769312
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26821,37,0.76 [0.44-1.30],0.3098982719464903
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,28381,69,0.94 [0.59-1.50],0.7911439635102662
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27385,138,0.70 [0.54-0.89],0.0046303985456741
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28267,162,0.84 [0.64-1.11],0.229732276017425
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27995,33,0.63 [0.40-0.99],0.0444424280388507
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26839,55,1.18 [0.66-2.14],0.5750342681228989
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27923,1139,0.84 [0.75-0.93],0.0009431268776762
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",27111,327,1.02 [0.82-1.28],0.8412072504645683
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26825,41,0.76 [0.45-1.27],0.2912807854423362
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28382,277,0.76 [0.62-0.93],0.0067464671634853
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,28026,64,1.01 [0.60-1.71],0.958630662763154
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28332,227,0.81 [0.64-1.02],0.0725273992688022
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28431,189,1.08 [0.79-1.47],0.623342120981836
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26910,126,0.94 [0.66-1.34],0.7277760093975385
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26981,197,1.14 [0.84-1.55],0.3942178831733576
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28421,179,1.10 [0.80-1.51],0.5549986427288391
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26918,134,0.65 [0.51-0.81],0.000211977431112
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28432,120,1.11 [0.75-1.64],0.6039601149183369
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24993,136,0.56 [0.46-0.70],1.0169031289666089e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26584,4805,0.87 [0.83-0.92],1.6138276549472506e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,25166,3387,0.88 [0.83-0.94],0.000194383224227
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24954,97,0.70 [0.50-0.96],0.0281100304077537
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25549,159,0.91 [0.67-1.23],0.5473504807956848
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25556,166,0.83 [0.63-1.11],0.2076270364260029
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,28229,118,0.80 [0.57-1.11],0.173318521324373
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25437,47,0.66 [0.44-0.99],0.0472125386826567
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22550,771,0.91 [0.79-1.05],0.2061973701422186
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28405,128,0.84 [0.61-1.16],0.2870034646744722
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25692,302,0.88 [0.71-1.10],0.2548062361987219
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24906,6448,0.88 [0.84-0.93],5.046947966399825e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,27054,111,0.74 [0.54-1.00],0.0500883031619647
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24977,120,0.77 [0.56-1.05],0.0985210931759802
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25479,622,1.04 [0.88-1.23],0.6699574916493428
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27548,2158,0.91 [0.84-0.99],0.0291596917687571
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,25087,230,0.88 [0.68-1.13],0.304892333614106
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,25151,294,0.72 [0.59-0.88],0.0011907295163602
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,25010,153,1.22 [0.85-1.75],0.2845797853019425
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27933,37,0.84 [0.46-1.56],0.5918999254481125
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,23132,1353,0.85 [0.77-0.94],0.0015760594452459
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,22193,414,0.84 [0.71-1.01],0.0576904542720656
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28411,404,0.86 [0.72-1.02],0.0850542698703747
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21851,72,0.77 [0.51-1.15],0.2024808563729318
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),22133,354,0.86 [0.70-1.05],0.1457722458324815
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25197,340,0.95 [0.77-1.19],0.6744566180170894
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22571,792,1.06 [0.91-1.23],0.4553337029991736
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,25420,30,0.66 [0.39-1.10],0.1117945055871201
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25958,568,0.85 [0.72-0.99],0.0322256254792243
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25679,289,0.86 [0.69-1.07],0.1744222843375786
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22516,737,1.06 [0.91-1.25],0.4362294802849921
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24946,89,1.27 [0.79-2.06],0.3211405226172609
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24921,64,0.78 [0.50-1.21],0.2694070630211695
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,27000,57,0.76 [0.49-1.16],0.1991096914463566
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,28121,1178,0.81 [0.73-0.89],4.438440361335965e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27610,667,0.79 [0.69-0.91],0.000732590021395
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28355,357,0.76 [0.64-0.92],0.0037299093023429
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23602,1823,0.82 [0.75-0.89],3.364696969503805e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21863,84,0.76 [0.52-1.11],0.1592813152345975
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24939,82,0.63 [0.46-0.86],0.0036311857410319
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21807,28,1.00 [0.46-2.16],0.9986213138647192
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21893,114,0.90 [0.62-1.30],0.5800151035179659
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27181,238,0.88 [0.69-1.12],0.2962486029631913
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,27195,252,0.83 [0.66-1.05],0.1189551561696625
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28424,85,0.64 [0.47-0.86],0.0035457569256655
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",27001,1611,0.92 [0.83-1.01],0.0768388623792583
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24980,123,0.75 [0.55-1.03],0.0714344760592583
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21898,119,0.75 [0.55-1.03],0.0793104889222372
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,26043,653,0.94 [0.81-1.10],0.429013866080313
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23882,2103,0.85 [0.79-0.93],0.0001768150561337
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27957,61,0.72 [0.48-1.09],0.1219327846336313
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28442,77,0.75 [0.51-1.08],0.1230708316237466
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24942,85,1.24 [0.76-2.01],0.3921152874533072
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25996,1139,0.89 [0.79-1.00],0.0439163535844787
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24928,71,0.80 [0.53-1.22],0.3001582082613649
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22941,1162,0.85 [0.76-0.95],0.0033108053422129
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,27048,105,1.02 [0.68-1.53],0.9118248694126926
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24928,71,1.34 [0.78-2.30],0.2950170649169766
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,25508,118,0.69 [0.52-0.92],0.0116223564499606
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25274,417,0.87 [0.72-1.04],0.1304965023180115
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,28110,214,0.71 [0.57-0.89],0.0022555878654832
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25867,477,0.89 [0.75-1.06],0.200082096779165
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28364,337,0.79 [0.65-0.96],0.0154286278121153
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28448,38,0.66 [0.41-1.07],0.093668459145768
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,25066,209,0.79 [0.62-1.00],0.0539492730275254
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22846,615,0.78 [0.68-0.90],0.0007472290452862
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25373,516,0.85 [0.72-1.01],0.0572984150464116
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],25030,173,0.88 [0.66-1.17],0.3901280684912366
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21815,36,0.57 [0.37-0.89],0.0137002468623491
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23614,1835,0.81 [0.74-0.88],9.043586084451248e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22250,471,0.78 [0.66-0.91],0.0020902795788704
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27982,86,0.83 [0.56-1.23],0.3537346069352701
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28391,52,0.60 [0.42-0.85],0.0045090510039083
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26811,29,1.01 [0.46-2.20],0.9806432701828276
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21858,79,0.73 [0.50-1.06],0.0976935985822475
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,25484,94,0.77 [0.54-1.09],0.1363009586098901
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22140,361,0.73 [0.61-0.87],0.0004322801648031
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,25137,280,0.86 [0.68-1.08],0.1893986342665474
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25610,220,1.08 [0.81-1.44],0.6075121372234082
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,25500,110,0.93 [0.64-1.35],0.690560525572852
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,24114,49,0.53 [0.38-0.75],0.0003753096153824
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28451,41,0.65 [0.41-1.01],0.0565152283245877
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25478,621,0.77 [0.67-0.89],0.000240974099762
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27987,91,0.61 [0.46-0.81],0.000641849220192
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27346,2489,0.91 [0.84-0.98],0.0126178998203342
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24971,114,0.71 [0.53-0.96],0.0283164463892244
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25757,367,1.09 [0.87-1.36],0.4520262685415227
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,27026,192,0.70 [0.56-0.88],0.0020650663751358
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25545,155,0.99 [0.71-1.37],0.9358874916187442
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26481,1091,0.89 [0.79-1.00],0.056770019239384
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,26117,727,0.89 [0.77-1.03],0.1112359709751834
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24904,47,0.50 [0.36-0.69],2.0653953416132946e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,28046,150,0.64 [0.51-0.81],0.0002166085090018
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,25018,161,1.40 [0.97-2.02],0.0740569235301047
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24918,61,0.86 [0.52-1.41],0.5473187019479511
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21817,38,0.76 [0.43-1.33],0.3310393219924037
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27884,891,0.82 [0.73-0.92],0.0010904448483773
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11579,78,0.90 [0.58-1.39],0.6290695479520242
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15381,78,0.69 [0.48-0.98],0.0403034452407791
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28156,336,0.86 [0.71-1.05],0.1399369525253387
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27882,62,0.85 [0.55-1.33],0.4762961654229573
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27714,721,0.83 [0.73-0.95],0.0060603182628036
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,28269,33,0.81 [0.45-1.45],0.4734031222956706
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,28281,196,1.00 [0.75-1.34],0.9759242569692466
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Cystitis,26179,169,0.86 [0.65-1.15],0.3043553823668138
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Dialysis,27055,62,1.07 [0.63-1.80],0.8129646903872753
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12282,1168,0.97 [0.87-1.08],0.5764352953961356
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15511,208,0.79 [0.62-1.01],0.0635197022174884
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,11645,144,1.15 [0.80-1.65],0.464083583306428
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11901,400,1.00 [0.82-1.23],0.9651485126293192
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11942,441,0.82 [0.69-0.97],0.018963677694627
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,24008,4422,0.91 [0.86-0.96],0.0013035113744319
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,28306,70,0.80 [0.53-1.20],0.2809909528807593
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,11204,90,0.99 [0.66-1.48],0.9540541278486492
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26908,236,0.81 [0.65-1.02],0.0727667377505125
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11890,776,0.95 [0.83-1.09],0.4733314080306408
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15371,246,0.97 [0.74-1.26],0.7961132969465492
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11222,108,0.97 [0.67-1.42],0.8935619899692431
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,15379,129,1.06 [0.73-1.55],0.7563324520316882
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11809,308,1.05 [0.82-1.33],0.711087003938091
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,26079,69,0.74 [0.51-1.07],0.1108634001102787
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12963,1462,0.95 [0.85-1.05],0.3137162246654786
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,11162,48,0.73 [0.48-1.10],0.1331266212724172
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11605,104,0.88 [0.61-1.28],0.5104629918461723
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28455,41,0.91 [0.50-1.67],0.7590496077669607
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28461,48,0.73 [0.46-1.17],0.1887670779320126
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27574,1564,0.90 [0.81-0.99],0.0233997218821233
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26500,490,0.88 [0.75-1.05],0.1502805167872613
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15373,70,0.98 [0.60-1.59],0.9212727434909336
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28414,329,0.85 [0.70-1.04],0.1130226501351922
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11269,155,0.81 [0.62-1.06],0.1260513553953823
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11232,118,0.98 [0.69-1.39],0.8981891928622745
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11192,78,0.74 [0.53-1.04],0.0822367418089846
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28427,55,0.64 [0.44-0.94],0.0236199385478905
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,27139,1129,0.82 [0.74-0.92],0.0004006583324618
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15252,127,1.35 [0.89-2.04],0.1624357496127032
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11591,90,0.91 [0.60-1.36],0.6361655249708928
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11738,237,1.08 [0.82-1.44],0.574239067098697
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11563,62,0.93 [0.56-1.53],0.7610633953045883
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11609,108,0.75 [0.54-1.03],0.0764979273781259
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26942,270,0.80 [0.65-0.99],0.0429831093501894
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,28201,116,0.76 [0.56-1.03],0.0817274339540712
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11689,188,1.15 [0.84-1.59],0.3889155405400399
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11584,83,0.77 [0.53-1.11],0.1651432884312282
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11947,446,0.98 [0.81-1.19],0.8453675260984866
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11571,70,0.86 [0.55-1.35],0.5135990037251811
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11896,395,1.00 [0.81-1.23],0.9964419378789836
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,28286,50,0.96 [0.55-1.67],0.8822044945372568
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11224,110,1.06 [0.73-1.55],0.7638717766639154
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,28257,1585,0.84 [0.77-0.92],0.0002089307107183
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26818,146,0.81 [0.60-1.10],0.1723859881114385
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,27074,81,0.78 [0.54-1.12],0.1791350057579002
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27893,73,0.81 [0.54-1.21],0.3038491296776667
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26185,175,1.27 [0.91-1.78],0.1606772896873852
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28221,401,0.86 [0.72-1.03],0.1114209115352655
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11607,106,0.80 [0.57-1.13],0.2097254619183181
